Henrik Lund
Direktor/Vorstandsmitglied bei Oslo Cancer Cluster NCE
Profil
Henrik Lund is currently the Director at Oslo Cancer Cluster NCE and MedCoast Scandinavia.
Previously, he was the Chief Executive Officer and Head-Investor Relations at NEL ASA in 2012 and the CEO and Investor Relations Officer at Bionor Pharma ASA in 2011.
Aktive Positionen von Henrik Lund
| Unternehmen | Position | Beginn |
|---|---|---|
Oslo Cancer Cluster NCE
 Oslo Cancer Cluster NCE Miscellaneous Commercial ServicesCommercial Services Oslo Cancer Cluster NCE is an oncology research firm that specializes in developing cancer diagnostics and medicines. The private company is based in Oslo, Norway. | Direktor/Vorstandsmitglied | 17.06.2011 |
| MedCoast Scandinavia | Direktor/Vorstandsmitglied | 17.06.2011 |
Ehemalige bekannte Positionen von Henrik Lund
| Unternehmen | Position | Ende |
|---|---|---|
Bionor Pharma ASA
 Bionor Pharma ASA Pharmaceuticals: OtherHealth Technology Bionor Pharma ASA engages in research and development, patenting, and commercialization of products in the pharmaceuticals and biotech industry. The company focuses on the research and development of peptide-based vaccines against viral diseases, primarily HIV. The company was founded on January 2, 1993 and is headquartered in Oslo, Norway. | Präsident | 15.08.2011 |
| NEL ASA | Vorsitzender | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| NEL ASA | Producer Manufacturing |
| Private Unternehmen | 3 |
|---|---|
Oslo Cancer Cluster NCE
Oslo Cancer Cluster NCE Miscellaneous Commercial ServicesCommercial Services Oslo Cancer Cluster NCE is an oncology research firm that specializes in developing cancer diagnostics and medicines. The private company is based in Oslo, Norway. | Commercial Services |
Bionor Pharma ASA
Bionor Pharma ASA Pharmaceuticals: OtherHealth Technology Bionor Pharma ASA engages in research and development, patenting, and commercialization of products in the pharmaceuticals and biotech industry. The company focuses on the research and development of peptide-based vaccines against viral diseases, primarily HIV. The company was founded on January 2, 1993 and is headquartered in Oslo, Norway. | Health Technology |
| MedCoast Scandinavia |
